Clinical physicians typically rely on their clinical experience and guidelines to determine whether to perform pre-surgical hs-cTnT testing, which may include recent myocardial infarction, recent acute myocardial injury, known coronary artery disease, known heart failure, and symptoms of angina. This evidence concerns the gene TNNT2 and angina pectoris.